AAAAAA

   
Results: 1-7 |
Results: 7
Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain
Authors: Atanassoff, PG Hartmannsgruber, MWB Thrasher, J Wermeling, D Longton, W Gaeta, R Singh, T Mayo, M McGuire, D Luther, RR
Citation: Pg. Atanassoff et al., Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain, REG ANES PA, 25(3), 2000, pp. 274-278
Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial
Authors: Tumlin, JA Dunbar, LM Oparil, S Buckalew, V Ram, CV Mathur, V Ellis, D McGuire, D Fellmann, J Luther, RR
Citation: Ja. Tumlin et al., Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial, ACAD EM MED, 7(6), 2000, pp. 653-662
Effects of an N-type calcium channel antagonist (SNX 111; ziconotide) on calcium-45 accumulation following fluid-percussion injury
Authors: Samii, A Badie, H Fu, K Luther, RR Hovda, DA
Citation: A. Samii et al., Effects of an N-type calcium channel antagonist (SNX 111; ziconotide) on calcium-45 accumulation following fluid-percussion injury, J NEUROTRAU, 16(10), 1999, pp. 879-892
Prolonged fenoldopam infusions in patients with mild to moderate hypertension - Pharmacodynamic and pharmacokinetic effects
Authors: Taylor, AA Shepherd, AM Polvino, W Mangoo-Karim, R Ballard, K Sunthornyothin, S Luther, RR Pool, JL
Citation: Aa. Taylor et al., Prolonged fenoldopam infusions in patients with mild to moderate hypertension - Pharmacodynamic and pharmacokinetic effects, AM J HYPERT, 12(9), 1999, pp. 906-914
Fenoldopam: A new parenteral antihypertensive - Consensus roundtable on the management of perioperative hypertension and hypertensive crises
Authors: Oparil, S Aronson, S Deeb, GM Epstein, M Levy, JH Luther, RR Prielipp, R Taylor, A
Citation: S. Oparil et al., Fenoldopam: A new parenteral antihypertensive - Consensus roundtable on the management of perioperative hypertension and hypertensive crises, AM J HYPERT, 12(7), 1999, pp. 653-664
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: A dose-tolerabilitystudy
Authors: Taylor, AA Mangoo-Karim, R Ballard, KD Luther, RR Pool, JL
Citation: Aa. Taylor et al., Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: A dose-tolerabilitystudy, J CLIN PHAR, 39(5), 1999, pp. 471-479
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
Authors: Mathur, VS Swan, SK Lambrecht, LJ Anjum, S Fellmann, J McGuire, D Epstein, M Luther, RR
Citation: Vs. Mathur et al., The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects, CRIT CARE M, 27(9), 1999, pp. 1832-1837
Risultati: 1-7 |